Drug intelligence / Profile preview

ferrous sulfate + folic acid (Pierre Fabre Laboratories)

Development stage
Unknown
Lead developer
Pierre Fabre
Modality
Small Molecules
Administration
Oral
01

Overview

Tardyferon Fol is an oral, prolonged-release combination medication containing ferrous sulfate (an iron salt) and folic acid (vitamin B9). It is primarily indicated for the prevention and treatment of iron deficiency and iron deficiency anemia associated with folic acid deficiency, particularly during pregnancy, postpartum, and lactation. The formulation features a specialized controlled-release matrix that slowly releases the iron component in the gastrointestinal tract, which enhances absorption and improves gastrointestinal tolerability compared to standard immediate-release iron supplements. Folic acid is included as an essential cofactor to support DNA synthesis, cell division, and erythropoiesis.

Brand names
Ferro-Tardyferon FolGyno-TardyferonTardyferon B9Tardyferon FolTardyferon-Fol
Other names
ferrous sulfate and folic acidiron and folic acidiron sulfate and folic acid
02

Targets

SLC11A2 (DMT1)SLC46A1 (Proton-coupled folate transporter)DHFR (Dihydrofolate reductase)FOLR1 (FRα)RFC1 (Reduced folate carrier type 1)

Beyond the preview

Go deeper on ferrous sulfate + folic acid (Pierre Fabre Laboratories).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ferrous sulfate + folic acid (Pierre Fabre Laboratories).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call